Community/Retail

Customer satisfaction with supermarket and drugstore chain pharmacies has improved in the last year, while ratings for mail-order and mass-merchandiser pharmacies have dropped, according to the J.D. Power 2015 US Pharmacy Study.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses some strategies pharmacists can use to support COPD management.

The historically black and Catholic Xavier University College of Pharmacy has received an $8.3 million grant from the US Department of Health and Human Services to encourage more African-American students to enter the pharmacy field.

The FDA today approved evolocumab (Repatha) injection, a new treatment for patients unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.

Celgene Corporation today announced it has closed its acquisition of Receptos, Inc.

Angela Patterson, MSN, chief nurse practitioner officer of the CVS MinuteClinic, talks about the roadblocks that pharmacists face in treating acne, and talks about how to overcome these problems.

Drug manufacturers spent $3.4 billion on advertising the top 10 brand-name prescription drugs last year.

Pharmacies are now stocking Mylan's generic version of Pfizer's Zosyn injection.

Jessica Kerr, PharmD, CDE, assistant department chair at Southern Illinois University Edwardsville, discusses what pharmacists should know about Afrezza.

A new type 2 diabetes (T2D) treatment for adult patients, empagliflozin and metformin (Synjardy), was approved by the FDA today.

What advice would you offer the younger you?

Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, talks about trends in diabetes management that pharmacists can participate in.

An estimated 6 to 12 million individuals in the United States develop head lice each year, with most cases occurring in children ages 3 to 11.

Novo Nordisk today announced that it has entered into a definitive agreement under which Novo Nordisk will acquire Calibrium LLC and MB2 LLC, two privately held biopharmaceutical research companies based in Indiana, US.

Novartis announced the winners of its twelfth annual International Biotechnology Leadership Camp (BioCamp), a three-day seminar bringing biotechnology and business experts together with 70 selected students from leading international universities in 24 countries and territories.

CVS Health has entered into new clinical affiliations with St. Luke's University Health Network in Bethlehem, Pennsylvania, and TriHealth in Cincinnati, Ohio.

The National Association of Chain Drug Stores today announced the winners of the 2015 NACDS Total Store Expo Product Showcase.

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses recent technologies that have the highest potential to improve communications between patients and pharmacists.

Amneal today announced the creation of Amneal Biosciences, a wholly-owned subsidiary of Amneal Pharmaceuticals LLC.

In light of last year's severe flu season, the US Centers for Disease Control and Prevention (CDC) urges pharmacists to recognize their key role in promoting influenza immunizations.

Ingenol mebutate (Picato) gel's label must now include reported risks of shingles and anaphylaxis.

Holding a college degree is not only associated with a better chance at landing a job. Graduates also benefit more from exercise to prevent and manage diabetes than other populations, new research suggests.

The prevalence of hypertension increases with age, so much so that patients 65 and older frequently receive this diagnosis.

Valeant Pharmaceuticals International, Inc. today announced the addition of D. Robert Hale, Partner of ValueAct Capital, to its board of directors and the resignation of Jeffrey W. Ubben, CEO and CIO of ValueAct Capital.

Did you know that about 73% of antibiotics are inappropriately prescribed every year?

Every house has that half-used bottle of antibiotics sitting in the back of the medicine cabinet.

There are immense oppurtunities to transform the inhaler into a tool that tracks patients' use of asthma and COPD medications.